Hemophilia A

Roughly half of people with haemophilia A have the severe form, and as many as a third develop inhibitors to factor replacement.1

Even after five years on the best available prophylaxis, patients average about one treated bleed a year and some have five.2

one armthe otheractivationFactor IXaFactor XBispecificPhospholipidmembraneFactor Xaone armthe otheractivationFactor IXaFactor XBispecificPhospholipidmembraneFactor Xa
1 in 21
people with haemophilia A have the severe form
1 in 31
develop inhibitors to factor replacement
12
treated bleed a year on the best available prophylaxis, at the average

Our ambition is a haemophilia that asks for attention a few times a year.

Please note: Solantis Bio operates in a stealth capacity.

Messages arrive with the people doing the work. We keep your details for correspondence and no other purpose. Your data.